3-Year Follow-Up After Uniportal Thoracoscopic Sympathicotomy for Hyperhidrosis: Undesirable Side Effects

Basit Öğe Kaydı
dc.authoridkuzucuoğlu, mustafa/0000-0001-9889-0061
dc.authoridkaramustafaoglu, yekta altemur/0000-0002-5491-1219
dc.authoridYANIK, FAZLI/0000-0002-8931-5329
dc.authoridYORUK, YENER/0000-0001-6309-3054
dc.authoridsagiroglu, gonul/0000-0002-1189-4973
dc.authorwosidkuzucuoğlu, mustafa/R-5469-2016
dc.authorwosidYanık, Fazlı/W-4597-2017
dc.authorwosidkaramustafaoglu, yekta altemur/S-9512-2019
dc.authorwosidSagiroglu, Gonul/ABH-1345-2021
dc.authorwosidYoruk, Yener/W-4285-2017
dc.authorwosidsagiroglu, gönül/AAB-4472-2021
dc.contributor.authorKaramustafaoglu, Yekta Altemur
dc.contributor.authorKuzucuoglu, Mustafa
dc.contributor.authorYanik, Fazli
dc.contributor.authorSagiroglu, Gonul
dc.contributor.authorYoruk, Yener
dc.date.accessioned2024-06-12T11:18:47Z
dc.date.available2024-06-12T11:18:47Z
dc.date.issued2014
dc.departmentTrakya Üniversitesien_US
dc.description.abstractObjective: Endoscopic thoracic sympathectomy or sympathicotomy, for the treatment of palmar, axillary, and plantar hyperhidrosis, is generally performed at one or two levels, between T2 and T5. Compensatory sweating (CS) is a severe and undesirable side effect of this procedure. Here, we describe the success of treatment and degree of postoperative CS in sympathicotomy patients. Subjects and Methods: This study included 80 patients treated by uniportal (5-mm) thoracoscopic sympathicotomy (electrocautery) for primary hyperhidrosis over a 6-year period (2007-2013). Sympathicotomy was performed bilaterally at T2 for blushing (n=2), T2-T3 for palmar-only hyperhidrosis (n=34), T2-T4 for palmar and axillary hyperhidrosis (n=39), and T3-T4 for axillary-only hyperhidrosis (n=5). Outcome was assessed 2 weeks postsurgery at the clinic and annually thereafter by telephone questionnaire. Mean follow-up time was 35.2 +/- 23.3 months. Questionnaires assessed patients' degree of sweating, postoperative CS, overall satisfaction, and complications. Results: Seventy-one patients (88.7%) were very satisfied, whereas only 9 (11.3%) were dissatisfied with the procedure. Complication incidence was 7.5%, and CS occurred in 77.5% of patients. Therapeutic success rate was 97.5%; complete relief of hyperhidrosis was achieved in 72 (90%) patients, whereas 8 (10%) experienced recurrence. Conclusions: CS is a frequent side effect of thoracoscopic sympathicotomy. We recommend all patients undergoing this procedure should be warned of the potential risk of developing severe CS.en_US
dc.identifier.doi10.1089/lap.2014.0380
dc.identifier.endpage785en_US
dc.identifier.issn1092-6429
dc.identifier.issn1557-9034
dc.identifier.issue11en_US
dc.identifier.pmid25376004en_US
dc.identifier.scopus2-s2.0-84912048939en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage782en_US
dc.identifier.urihttps://doi.org/10.1089/lap.2014.0380
dc.identifier.urihttps://hdl.handle.net/20.500.14551/24966
dc.identifier.volume24en_US
dc.identifier.wosWOS:000344387700006en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherMary Ann Liebert, Incen_US
dc.relation.ispartofJournal Of Laparoendoscopic & Advanced Surgical Techniquesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectEndoscopic Thoracic Sympathectomyen_US
dc.subjectPalmar Hyperhidrosisen_US
dc.subjectCompensatory Hyperhidrosisen_US
dc.subjectSatisfactionen_US
dc.subjectAblationen_US
dc.subjectSurgeryen_US
dc.title3-Year Follow-Up After Uniportal Thoracoscopic Sympathicotomy for Hyperhidrosis: Undesirable Side Effectsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu